Palliation Of Incurable Gastric Cancer
INTRODUCTION Print Section Listen Gastric cancer remains a leading cause of cancer death worldwide. It is estimated that 26,370 people will be diagnosed with gastric cancer in the United States…
Multimodality Therapy of Gastric Cancer: Eastern Experience
INTRODUCTION Print Section Listen Several bodies of evidence both from the West and the East currently recommend that some form of adjuvant therapy should be delivered in addition to surgery…
Multimodality Therapy of Gastric Cancer: Western Experience
INTRODUCTION Print Section Listen Gastric cancer remains one of the most common malignancies and a high cause of mortality worldwide. In the United States and the Western world, the incidence…
Transhiatal Esophagectomy
INTRODUCTION Print Section Listen Surgery, either alone or in combination with other therapeutic options (chemotherapy and/or radiotherapy), remains an essential component of a multimodality approach to midstage esophageal cancer and…
Surgical and Multimodality Treatments of Cancers at the Esophagogastric Junction: The Eastern Perspective
INTRODUCTION Print Section Listen The incidence of gastric adenocarcinoma in the East is much higher than in the West; the main etiology is Helicobacter pylori (H. pylori) infection. However, in…
Minimally Invasive Surgical Resection for Mid-Stage Gastric Cancer
BACKGROUND AND EPIDEMIOLOGY Print Section Listen Gastric cancer is a global health problem with an estimated one million new cases diagnosed a year.1 It is the third and fifth leading…
Early Gastric Cancer: Local, Endoscopic Options
INTRODUCTION Print Section Listen As the technology continues to evolve, endoscopy has become not only an imaging modality but also a therapeutic instrument as one of the minimally invasive treatment…
Esophagogastric Junction Cancer: Definition, Staging Aspects, and Therapeutic Implications
INTRODUCTION Print Section Listen Diagnosis and therapy of cancers of the esophagogastric junction (EGJ) tend to be accompanied by some unique and specific challenges. Some of these result from the…
Palliation of Incurable Esophageal Cancer
INTRODUCTION Print Section Listen Generally, cancer of the esophagus and gastroesophageal junction carries with it a poor prognosis. The expected 5-year survival with esophageal cancer is 40%, 21%, and 4%,…
Multimodality Therapy for Esophageal Cancer: Eastern Experience
BACKGROUND Print Section Listen The majority of esophageal carcinomas are represented by two histologies: squamous cell carcinoma and adenocarcinoma. Esophageal squamous cell carcinoma (ESCC) is the predominant histological type in…
